The U.S. needs 140,000 new senior housing units annually to keep pace with its aging population, nearly six times the current ...

Alexandria Real Estate Equities Inc. closed 40.82% short of its 52-week high of $130.14, which the company achieved on July ...

Alexandria Real Estate Equities owns a monopoly on top-tier biotech lab real estate, with long-term leases and blue-chip tenants in innovation hubs. Learn more on ARE stock here.

Alexandria Real Estate Equities, Inc. Releases 2024 Corporate Responsibility Report Highlighting Its Strategic Initiatives That Catalyze Positive Change for the Benefit of Human Health and Advance ...

Alexandria Real Estate Equities, Inc. (ARE), an S&P 500 company, is a leading life science REIT that has pioneered the development of collaborative Megacampus ecosystems in premier innovation ...

Blue-chip dividend stocks are truly hard to find, particularly when investors start looking for names with big dividend yields that also provide relative stability (and Wall Street analysts think ...

The post Alexandria Real Estate, Altria and Dow Inc. Are Big Dividend Stocks That Are Poised to Soar appeared first on 24/7 Wall St..

Shares of Alexandria Real Estate Equities Inc. ARE shed 2.53% to $72.18 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0 ...

Investors were bearish on the equity of Alexandria Real Estate Equities (NYSE: ARE) throughout Tuesday's trading session.

Alexandria Real Estate Equities, Inc. Reports: 1Q25 Net Loss per Share - Diluted of $ (0.07); and 1Q25 FFO per Share - Diluted, as Adjusted, of $2.30 ...

Life sciences-focused REIT Alexandria Real Estate Equities will execute a $500M stock buyback program, according to a Monday press release, and may purchase outstanding common stock through Dec ...